The report supports the fact that the doctors should offer a daily dose of HIV prevention pill to the healthy people who are highly probable to get infected. The new guidelines may help cut the nearly 40,000 new HIV infections in the US each year.
Regular consumption of HIV prevention pill for the healthy people who are prone to get infected HIV can prevent themselves from the disease. The recommendations were published in the Journal of the American Medical Association. The U.S. Preventive Services Task Force usually advice that everyone ages between 15 to 65 and any pregnant woman should be regularly screened, though the latest recommendation is a step ahead to cure the disease at the initiation stage.
The drug is called PrEP, or preexposure prophylaxis, and a two-medication combo pill named Truvada is sanctioned for the precautionary use in the U.S. The task force declared that the PrEP is only for people who is probable of infection, due to various reasons such as living with an HIV-positive sex partner; or having unprotected sex with someone who is at high risk of HIV; or shares common needles to inject drugs.
Susan Buchbinder and Drs. Diane Havlir from the University of California, San Francisco wrote in JAMA Internal Medicine about the doubtful success of the research report as the cost can be a major barrier. The average monthly retail cost without insurance is nearly $2,000. Thus the federal government announced that Truvada maker Gilead Sciences Inc. has approved a donation of PrEP doses for up to 200,000 people a year, for the uninsured people.
Currently, 1.1 million people are living with HIV in the U.S.